1. Glucose tolerance test with a single abnormal value in pregnancy and the risk of type-2 diabetes mellitus
- Author
-
Eran Hadar, Hadas Zafrir-Danieli, Alexandra Berezowsky, Eyal Krispin, Amir Aviram, and Oded Raban
- Subjects
medicine.medical_specialty ,Glucose tolerance test ,Pregnancy ,endocrine system diseases ,medicine.diagnostic_test ,business.industry ,nutritional and metabolic diseases ,Obstetrics and Gynecology ,Type 2 Diabetes Mellitus ,Retrospective cohort study ,General Medicine ,medicine.disease ,Gastroenterology ,Gestational diabetes ,Interquartile range ,Internal medicine ,Diabetes mellitus ,Cohort ,medicine ,business - Abstract
To evaluate the association between a single abnormal value on a 3-h 100 g oral glucose tolerance test (OGTT) results and future type-2 diabetes mellitus (Type-2 DM). Retrospective cohort study of women between 18 and 45 years of age who underwent a 3-h OGTT during pregnancy and delivered in a tertiary medical center between 2007 and 2014. The women were followed for a median period of 64 months postpartum. According to OGTT values, women were divided into three groups: normoglycemic (normal OGTT), single abnormal OGTT value (SAV) and gestational diabetes mellitus (two or more abnormal OGTT values, GDM). General pre-pregnancy characteristics, cardiovascular risk factors and future diagnosis of Type-2 DM, as the primary outcome, were recorded. During the study period, 5295 women underwent an OGTT and were followed for a median period of 64 months (interquartile range of 32). The cohort was divided as following: 3639 (68.73%) were normoglycemic, 854 (16.13%) had a SAV in the OGTT and 802 (15.15%) were diagnosed with GDM. Compared with normoglycemic controls, women with SAV and GDM tended to be older (32.20, 33.10 and 31.35 years for SAV, GDM and controls, respectively, p
- Published
- 2021